Compensatory Hypertrophy and Changes of Liver Function After Sequential Transarterial Chemoembolization, Stereotactic Body Radiotherapie, and Immunotherapy (START-FIT) in Unresectable Hepatocellular Carcinoma
Sequential transarterial chemoembolization (TACE), stereotactic body radiotherapie (SBRT), and immunotherapy (START-FIT) has shown its promising potential as a downstaging therapy of unresectable hepatocellular carcinoma (HCC).
Abstract (original)
Sequential transarterial chemoembolization (TACE), stereotactic body radiation therapy (SBRT), and immunotherapy (START-FIT) has shown its promising potential as a downstaging therapy of unresectable hepatocellular carcinoma (HCC). This study aims to analyze the dynamic changes in liver volume and hepatic function following START-FIT.
Dit artikel is een samenvatting van een publicatie in Int J Radiation Oncology. Voor het volledige artikel, alle details en referenties verwijzen wij u naar de oorspronkelijke bron.
Lees het volledige artikelDOI: 10.1016/j.ijrobp.2025.12.019